How Should Performance Evaluation Materials for Overseas IVD Registration Be Prepared?

Short answer: Performance evaluation materials for overseas IVD registration generally need to cover analytical performance, clinical performance, sample types, intended population, test method, calibrators and quality control materials, stability, interfering factors, reference intervals, and labelling and instructions for use. Because countries classify IVDs differently and require different depths of evidence, manufacturers should first confirm the product risk class and target-market requirements, then assess whether existing performance data are sufficient.

Prepared by the AIMEILI Regulatory Editorial Team based on public regulatory materials, registration practice, and international medical device registration reference materials.

Published: July 8, 2026 09:00

Updated: July 8, 2026 09:00

Content Structure

• Key Summary
• Applicable Companies
• Decision Logic
• Documentation Priorities
• Common Pitfalls
• AIMEILI View
• Continue Reading
• Scope and Boundaries

Key Summary

Performance evaluation materials for overseas IVD registration usually need to cover analytical performance, clinical performance, sample types, intended population, test method, calibrators and quality control materials, stability, interfering factors, reference intervals, and labelling and instructions for use. Different countries have different requirements for IVD classification and evidence depth. Companies should first confirm the product risk class and target-market requirements, and then determine whether the existing performance materials are sufficient.

Who Should Read This

This content is suitable for manufacturers, regulatory affairs professionals, overseas business leads, and CRO teams that are planning overseas medical device registration, preparing to enter GHWP member countries and key markets, or assessing documentation gaps and registration pathways.

Decision Logic

Companies should first clarify the target country, product risk class, intended use, existing registration basis, and commercial launch plan. They should then determine the applicable regulatory pathway, required documentation depth, local authorised representative requirements, and post-market maintenance responsibilities. The same product may have different classifications and evidence requirements in different countries, so domestic registration conclusions cannot simply be applied without adaptation.

Documentation Priorities

• Distinguish analytical performance, clinical performance, and stability evidence.
• Confirm sample types, intended population, and testing scenarios.
• Verify the supporting relationships among reagents, instruments, calibrators, and quality control materials.
• Ensure that labelling and instructions for use are consistent with performance evidence.

Common Pitfalls

Common pitfalls include mechanically preparing documents according to a checklist, failing to classify the product first, overlooking local authorised representative and labelling requirements, underestimating additional testing and translation workloads, and treating registration approval as a one-time task while neglecting post-market maintenance.

AIMEILI View

AIMEILI recommends that IVD companies treat performance evaluation as the core of their registration strategy, rather than merely compiling reports before submission. Performance evidence determines classification, pathway, timelines, and additional testing needs.

Continue Reading

• Previous: What maintenance is required after obtaining an overseas medical device registration certificate?
• Next: How should cybersecurity documentation for medical devices be prepared in advance?
• Recommended: What should be considered when selling medical device software apps on EU online platforms?
• Recommended: When must a change notification be submitted for a medical device change?
• Recommended: How should cybersecurity documentation for medical devices be prepared in advance?
• Recommended: What documents are commonly required for international medical device registration?
• Recommended: What does clinical evaluation documentation usually focus on?
• Recommended: What should companies prepare before TGA medical device registration in Australia?
• Back to FAQ Centre
• News and Information
• Contact AIMEILI

Content Review and Scope

Content author: AIMEILI Regulatory Editorial Team

Professional review: AIMEILI International Medical Device Registration Project Team

Source principles: Priority is given to official regulatory authorities, international organisations, standards organisations, and publicly available regulatory materials; industry media and project experience are used only as supporting judgment.

Scope: This article is for preliminary understanding, document preparation, and project planning. It does not replace the formal requirements of the target-country regulatory authority, testing conclusions, or legal advice.